Sodium‐Glucose Co‐Transporter Inhibitors and Atrial Fibrillation: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials

BACKGROUND: Sodium‐glucose co‐transporter (SGLT) inhibitors reduce cardiovascular outcomes including mortality in several populations; however, their effect on atrial fibrillation/flutter (AF) remains unclear. Our objective was to determine whether SGLT inhibitors reduce AF and whether a history of...

Descripción completa

Detalles Bibliográficos
Autores principales: Pandey, Arjun K., Okaj, Iva, Kaur, Hargun, Belley‐Cote, Emilie P., Wang, Jia, Oraii, Alireza, Benz, Alexander P., Johnson, Linda S. B., Young, Jack, Wong, Jorge A., Verma, Subodh, Conen, David, Gerstein, Hertzel, Healey, Jeff S., McIntyre, William F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Systematic Review and Meta‐analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649253/
https://www.ncbi.nlm.nih.gov/pubmed/34459238
http://dx.doi.org/10.1161/JAHA.121.022222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649253/
https://www.ncbi.nlm.nih.gov/pubmed/34459238
http://dx.doi.org/10.1161/JAHA.121.022222

Ejemplares similares